Vaccinex Announces Private Placement with Commitments of $5.

ROCHESTER, N.Y., April 03, 2023 -- Vaccinex, Inc. , a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the... | April 3, 2023

Related Keywords

Germany , John Mullaly , Maurice Zauderer , Albertd Friedberg , Merck Co Inc , Lifesci Advisors , Alzheimer Association , Nasdaq , Winship Cancer Institute Of Emory University , Drug Discovery Foundation , Exchange Commission , Merck Kga , Parent Co , Vaccinex Inc , Moffitt Cancer Center , Merck Kgaa , Drug Discovery , Winship Cancer Institute , Annual Report , Sci Advisors , Vaccinex , Nc Stock Exchange , News , Information , Press Release , Pril , 023 , Biotechnology , Company , Ioneering , Differentiated , Approach , O , Reating , Neurodegenerative , Disease , End , Dancer , Hrough Vcnx Us9186401033 ,